News
-
-
COMMUNIQUÉ DE PRESSE
PSI Software SE and Warburg Pincus enter into an Investment Agreement; Warburg Pincus announces Public Takeover Offer
Warburg Pincus announces Public Takeover Offer for PSI Software SE at EUR 45.00 per share in cash to strengthen market position and accelerate growth in energy and industrial software -
COMMUNIQUÉ DE PRESSE
PSI Software SE enters into Investment Agreement with Warburg Pincus to accelerate growth; public takeover offer announced
PSI Software SE enters into Investment Agreement with Warburg Pincus to accelerate growth; public takeover offer announced. Warburg Pincus, partnership, strategic, software company, acquisition -
COMMUNIQUÉ DE PRESSE
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
ONWARD Medical reports successful Q3 2025 with 40 ARC-EX Systems sold, regulatory milestones achieved, science & tech advancements highlighted, and record revenue surpassing EUR 1 million -
-
-
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
BIOPHYTIS et un consortium d'investisseurs lancent le premier essai clinique de Phase 3 dans la sarcopénie, avec une coentreprise à Hong Kong et un investissement de 20 M$. Opérations cliniques prévues début 2026 -
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026 -
COMMUNIQUÉ DE PRESSE
BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong -
COMMUNIQUÉ DE PRESSE
Touareg Group Expands Global Presence with Establishment of U.S. Technology Subsidiary
Touareg Group expands global presence by establishing U.S. technology subsidiary, focusing on AI, blockchain, and cryptocurrency exchange platforms. Strategic growth initiative at the convergence of finance and emerging technologies
